RECURRENT PERICARDITIS
Clinical trials for RECURRENT PERICARDITIS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PERICARDITIS trials appear
Sign up with your email to follow new studies for RECURRENT PERICARDITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to keep pericarditis Flare-Ups at bay
Disease control Recruiting nowThis study tests a new drug called KPL-387 in 80 people with well-controlled recurrent pericarditis (inflammation around the heart). The goal is to see if patients can safely switch from their current treatments to KPL-387 alone and still prevent flare-ups. The trial will measure…
Matched conditions: RECURRENT PERICARDITIS
Phase: PHASE2 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New shot aims to stop repeat heart sac inflammation
Disease control Recruiting nowThis study tests an injected drug called KPL-387 in 165 people with recurrent pericarditis, a condition where the sac around the heart becomes inflamed again and again. The goal is to see if KPL-387 can reduce flare-ups and pain better than a placebo. Participants must have sympt…
Matched conditions: RECURRENT PERICARDITIS
Phase: PHASE2, PHASE3 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for heart lining pain: can CardiolRx keep flare-ups away?
Disease control Recruiting nowThis study tests whether the drug CardiolRx can prevent another episode of pericarditis (inflammation around the heart) in people who have had repeated attacks. About 110 adults who have been stable on an IL-1 blocker for at least a year will stop that medication and receive eith…
Matched conditions: RECURRENT PERICARDITIS
Phase: PHASE3 • Sponsor: Cardiol Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for heart inflammation sufferers: experimental drug VTX2735 enters Mid-Stage trial
Disease control Recruiting nowThis study tests an experimental drug called VTX2735 in 50 adults with recurrent pericarditis, a condition where the heart's lining becomes inflamed and painful. The goal is to see if the drug is safe and can reduce pain and inflammation. Participants receive different doses over…
Matched conditions: RECURRENT PERICARDITIS
Phase: PHASE2 • Sponsor: Zomagen Biosciences Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC